CQDM Chemotherapy used to treat colorectal cancer is associated with serious side effects that often lead to treatment failure. In order to remedy this problem, Professor of the Department of Chemistry Borhane Annabi, holder of the Chair in Cancer Prevention and Treatment , in partnership with the biopharmaceutical company Theratechnologies, is developing an innovative therapeutic approach aimed at mitigating the side effects linked to chemotherapy. and to validate the safety of this targeted therapy for the treatment of colorectal cancer.
This $7.9 million project, supported by Theratechnologies and Mitacs, involves developing a unique anticancer peptide-drug conjugate platform that exploits the internalization functions of SORT1, a biomarker expressed in cancer cells. colorectal. The project is among three promising innovations in the fight against cancer, supported by the CQDM . This non-profit biopharmaceutical research consortium's mission is to support and facilitate collaborative research and development with the aim of transforming innovative technologies into solutions addressing unmet medical needs, while generating significant benefits for the economy. Quebec and Canadian.
“It is with great humility that our research team within the Chair in Cancer Prevention and Treatment welcomes this recognition,” emphasizes Borhane Annabi. CQDM has been incredibly supportive since the beginning of our project to develop a drug against colorectal cancer, without forgetting the unwavering support of our biopharmaceutical partner Theratechnologies. While Quebec now offers colorectal cancer screening to the population, the tangents that any initiative will take in the development of personalized treatment become significant in our fight against this cancer in Quebec.
It was on February 4, World Cancer Day, that the CQDM announced the funding of research and development projects carried out by three Quebec teams, funding made possible thanks to a grant of more than $2.4 million from the Government of Quebec.
You can discover the three collaborative research projects, with a total value of more than $12 million, by visiting the CQDM website .